Morpholine → 2-[(4-{2-[(5-Ethylpyrimidin-2-yl)(4-morpholin-4-ylbenzyl)amino]ethyl}-1,3-thiazol-2-yl)thio]-2-methylpropionic acid tert-butyl ester
Reaction equation
C(P(C(C)(C)C)C1C=CC=CC=1C1C=CC=CC=1)(C)(C)C.CC(C)([O-])C.[Na+].[C:28]([O:32][C:33](=[O:62])[C:34]([S:37][C:38]1[S:39][CH:40]=[C:41]([CH2:43][CH2:44][N:45]([CH2:54][C:55]2[CH:60]=[CH:59][C:58](Br)=[CH:57][CH:56]=2)[C:46]2[N:51]=[CH:50][C:49]([CH2:52][CH3:53])=[CH:48][N:47]=2)[N:42]=1)([CH3:36])[CH3:35])([CH3:31])([CH3:30])[CH3:29].[NH:63]1[CH2:68][CH2:67][O:66][CH2:65][CH2:64]1>C1(C)C=CC=CC=1.C1C=CC(/C=C/C(/C=C/C2C=CC=CC=2)=O)=CC=1.C1C=CC(/C=C/C(/C=C/C2C=CC=CC=2)=O)=CC=1.C1C=CC(/C=C/C(/C=C/C2C=CC=CC=2)=O)=CC=1.[Pd].[Pd]>[C:28]([O:32][C:33](=[O:62])[C:34]([S:37][C:38]1[S:39][CH:40]=[C:41]([CH2:43][CH2:44][N:45]([C:46]2[N:51]=[CH:50][C:49]([CH2:52][CH3:53])=[CH:48][N:47]=2)[CH2:54][C:55]2[CH:60]=[CH:59][C:58]([N:63]3[CH2:68][CH2:67][O:66][CH2:65][CH2:64]3)=[CH:57][CH:56]=2)[N:42]=1)([CH3:36])[CH3:35])([CH3:31])([CH3:30])[CH3:29]Participants
7
Reactant 4
Product 1
Reagents, catalysts & solvents 2
Conditions
- Temperature
- 110 °C
Procedure
tris(Dibenzylideneacetone)dipalladium (32 mg), 2-(di-tert-butylphosphino)biphenyl (21 mg) and sodium tert-butoxide (73 mg) were added to a 20 mL screw cap test tube substituted with nitrogen, and a solution of 2-[(4-{2-[(4-bromobenzyl)(5-ethylpyrimidin-2-yl)amino]ethyl}-1,3-thiazol-2-yl)thio]-2-methylpropionic acid tert-butyl ester (400 mg) synthesized in Example 402-1 and morpholine (91 mg) in toluene (1.4 mL) was added thereto. The test tube was capped, and stirred at 110° C. for 8 hr. After cooling to room temperature, the solution was directly purified by silica gel chromatography (elution solvent; hexane:ethyl acetate=3:1 to 2:1) to give the title compound (200 mg) as a colorless oil.
Workup
- customcap test tube
- customThe test tube was capped
- temperatureAfter cooling to room temperature
- customthe solution was directly purified by silica gel chromatography (elution solvent; hexane:ethyl acetate=3:1 to 2:1)
Sources & evidence
- ORD record
- ord-4ad6bc93c9c34e318f2f4c7cd84f8df6
- Source dataset
- uspto-grants-2011_09
- Patent number
- US08026370B2
Reaction notes
Loading…